Accelerated access scheme means patients will get new treatments faster
The government has announced a new fast-track route into the NHS for “breakthrough” medicines and technologies. This will speed up the time it takes for patients to benefit from ground-breaking products for conditions such as cancer, dementia and diabetes.
From April 2018, the new accelerated access pathway will mean products with the greatest potential to change lives could be available up to four years earlier. It will be done by reducing the time it takes to negotiate evaluation and financial approvals before the NHS can purchase the products.
